dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Shaw, Alice Tsang |
dc.contributor.author | Bearz, A. |
dc.contributor.author | Camidge, D. R. |
dc.contributor.author | Bauman, J. R. |
dc.contributor.author | Solomon, Benjamin |
dc.date.accessioned | 2022-01-25T11:14:55Z |
dc.date.available | 2022-01-25T11:14:55Z |
dc.date.issued | 2021-05 |
dc.identifier.citation | Felip E, Shaw AT, Bearz A, Camidge DR, Solomon BJ, Bauman JR, et al. Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs. Ann Oncol. 2021 May;32(5):620–30. |
dc.identifier.issn | 0923-7534 |
dc.identifier.uri | https://hdl.handle.net/11351/6886 |
dc.description | Lorlatinib; Càncer de pulmó de cèl·lules no petites; ALK TKI de segona generació |
dc.description.sponsorship | This work was supported by Pfizer Inc. (no grant number). |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Annals of Oncology;32(5) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Proteïnes quinases - Inhibidors |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Protein Kinase Inhibitors |
dc.subject.mesh | /therapeutic use |
dc.title | Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.annonc.2021.02.012 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | inhibidores de proteínas cinasas |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1016/j.annonc.2021.02.012 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Felip E] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Spain. [Shaw AT] Massachusetts General Hospital, Boston, USA. [Bearz A] National Institute for Cancer Research, Aviano, Italy. [Camidge DR] University of Colorado, Aurora, USA. [Solomon BJ] Peter MacCallum Cancer Centre, Melbourne, Australia. [Bauman JR] Fox Chase Cancer Center, Philadelphia, USA |
dc.identifier.pmid | 33639216 |
dc.identifier.wos | 000640355800008 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |